The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways
Open Access
- 1 January 2016
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 291 (3), 1029-1052
- https://doi.org/10.1074/jbc.m115.689653
Abstract
No abstract availableFunding Information
- National Health and Medical Research Council (APP1062607, APP1037323, APP1060482, APP1048972, APP1083057)
- Cancer Institute NSW (12ECF2–17)
This publication has 77 references indexed in Scilit:
- ERBB4 confers metastatic capacity in Ewing sarcomaEMBO Molecular Medicine, 2013
- The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)Online Journal of Public Health Informatics, 2012
- N‐myc downstream regulated gene 1 modulates Wnt‐β‐catenin signalling and pleiotropically suppresses metastasisEMBO Molecular Medicine, 2012
- Convergence between Wnt-β-catenin and EGFR signaling in cancerMolecular Cancer, 2010
- The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-CadherinPLOS ONE, 2007
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisOncogene, 2007
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences of the United States of America, 2006
- Expression of the HER1–4 family of receptor tyrosine kinases in breast cancerThe Journal of Pathology, 2003
- Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimersThe EMBO Journal, 1998
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997